Management of community-acquired pneumonia in persons with spinal cord injury

Spinal Cord

Volumn 42, Issue 8, 2004, Pages 450-458

  Burns, S P ^a,b,c,g   Weaver, F M ^a,b,c,d   Parada, J P ^c,e   Evans, C T ^a,b,c   Chang, H ^a,b,c,f   Hampton, R Y ^a,b,c   Kapur, V ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

^f LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^g VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Antibiotics; Community acquired pneumonia; Disease management; Spinal cord injuries

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BRONCHUS SECRETION; CLINICAL ARTICLE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CENTER; HOSPITAL ADMISSION; HUMAN; IMAGING SYSTEM; INTUBATION; LABORATORY TEST; LENGTH OF STAY; MALE; MEDICAL INFORMATION; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; SPINAL CORD INJURY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HOSPITAL UNITS; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PRACTICE GUIDELINES; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SPINAL CORD INJURIES; UNITED STATES;

EID: 4243163203     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3101600     Document Type: Article

References (28)

1. De Vivo MJ, Black KJ, Stover SL. Causes of death during the first 12 years after spinal cord injury. Arch Phys Med Rehabil 1993; 74: 248-254.
2. DeVivo MJ, Stover SL. Long-term survival and causes of death. In: Stover SL, Whiteneck GG (eds.) Spinal Cord Injury. Clinical Outcomes from the Model Systems. Aspen Publishers, Inc.: Gaithersburg, MD, 1995, pp 289-316.
3. Chang HT, Evans CT, Weaver FM, Burns SP. Etiology and outcomes of veterans with spinal cord injury and disorder hospitalized with community-acquired pneumonia. Arch Phys Med Rehabil 2004, (in press).
4. Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000; 31: 347-382.
5. Niederman MS et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-1754.
6. Bartlett JG, Breiman RF, Mandell LA, File Jr TM. Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 1998; 26: 811-838.
7. Groah SL, Weitzenkamp D, Sett P, Soni B, Savic G. The relationship between neurological level of injury and symptomatic cardiovascular disease risk in the aging spinal injured. Spinal Cord 2001; 39: 310-317.
8. Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community- acquired pneumonia. Ann Intern Med 2003; 138: 109-118.
9. Fishburn MJ, Marino RJ, Ditunno Jr JF. Atelectasis and pneumonia in acute spinal cord injury. Arch Phys Med Rehabil 1990; 71: 197-200.
10. Wang AY, Jaeger RJ, Yarkony GM, Turba RM. Cough in spinal cord injured patients: the relationship between motor level and peak expiratory flow. Spinal Cord 1997; 35: 299-302.
11. Meehan TP et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278: 2080-2084.
12. Campbell SG, Marrie TJ, Anstey R, Dickinson G, Ackroyd-Stolarz S. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest 2003; 123: 1142-1150.
13. Rello J et al. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest 2003; 123: 174-180.
14. Arancibia F et al. Community-acquired pneumonia due to Gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med 2002; 162: 1849-1858.
15. Gilmore DS, Bruce SK, Jimenez EM, Schick DG, Morrow JW, Montgomerie JZ. Pseudomonas aeruginosa colonization in patients with spinal cord injuries. J Clin Microbiol 1982; 16: 856-860.
16. Karlowsky JA et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Int J Antimicrob Agents 2002; 19: 21-31.
17. Agency for Healthcare Research and Quality. Treatment of Pulmonary Disease Following Cervical Spinal Cord Injury. Agency for Healthcare Research and Quality: Rockville, MD, 2001.
18. Fine MJ et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
19. Arnold FW, Ramirez JA, McDonald LC, Xia EL. Hospitalization for community-acquired pneumonia: the pneumonia severity index vs clinical judgment. Chest 2003; 124: 121-124.
20. McCormick D et al. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am J Med 1999; 107: 5-12.
21. Dedier J, Singer DE, Chang Y, Moore M, Atlas SJ. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med 2001; 161: 2099-2104.
22. Lentino JR, Krasnicka B. Association between initial empirical therapy and decreased length of stay among veteran patients hospitalized with community acquired pneumonia. Int J Antimicrob Agents 2002; 19: 61-66.
23. Fine MJ et al. Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. Am J Med 2000; 109: 378-385.
24. Fine MJ et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275: 134-141.
25. Brancati FL, Chow JW, Wagener MM, Vacarello SJ, Yu VL. Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet 1993; 342: 30-33.
26. Koivula I, Sten M, Makela PH. Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch Intern Med 1999; 159: 1550-1555.
27. Jackson LA et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348: 1747-1755.
28. Nobunaga AI, Go BK, Karunas RB. Recent demographic and injury trends in people served by the model spinal cord injury care systems. Arch Phys Med Rehabil 1999; 80: 1372-1382.